Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer

Overview of attention for article published in BMC Cancer, July 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter: 5 X users

patent: 2 patents

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 37 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

NEW DIAGNOSTIC AND PROGNOSTIC MARKERS FOR OVARIAN CANCER

Application WO-2017178948-A1

World Intellectual Property Organisation (WIPO)

NUOVI MARCATORI DIAGNOSTICI E PROGNOSTICI PER IL CANCRO OVARICO

Application IT-UA20162478-A1

Italy

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.